Clarius Group, LLC Novartis Ag Transaction History

Clarius Group, LLC

$1.4 Billion
Q3 2024

A detailed history of Clarius Group, LLC transactions in Novartis Ag stock. As of the latest transaction made, Clarius Group, LLC holds 6,319 shares of NVS stock, worth $621,789. This represents 0.05% of its overall portfolio holdings.

Number of Shares

6,319

Previous 7,753 18.5%

Holding current value

$621,789

Previous $825,000 12.0%

% of portfolio

0.05%

Previous 0.06%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	SELL	$106.13 - $120.89 $152,190 - $173,356	-1,434 Reduced 18.5%	6,319 $726,000
Q2 2024 Jul 11, 2024	SELL	$92.57 - $107.37 $146,445 - $169,859	-1,582 Reduced 16.95%	7,753 $825,000
Q1 2024 Apr 17, 2024	SELL	$95.27 - $108.47 $60,591 - $68,986	-636 Reduced 6.38%	9,335 $902,000
Q4 2023 Jan 29, 2024	SELL	$92.27 - $101.54 $2,399 - $2,640	-26 Reduced 0.26%	9,971 $1.01 Million
Q3 2023 Oct 19, 2023	SELL	$94.73 - $105.13 $17,525 - $19,449	-185 Reduced 1.82%	9,997 $1.02 Million
Q2 2023 Aug 09, 2023	BUY	$92.52 - $104.91 $43,761 - $49,622	473 Added 4.87%	10,182 $1.03 Million
Q1 2023 Apr 17, 2023	SELL	$80.03 - $92.81 $72,987 - $84,642	-912 Reduced 8.59%	9,709 $893,000
Q4 2022 Jan 25, 2023	BUY	$75.55 - $92.52 $154,046 - $188,648	2,039 Added 23.76%	10,621 $964,000
Q3 2022 Oct 24, 2022	SELL	$74.61 - $87.26 $38,946 - $45,549	-522 Reduced 5.73%	8,582 $652,000
Q2 2022 Aug 10, 2022	BUY	$80.52 - $93.75 $274,090 - $319,125	3,404 Added 59.72%	9,104 $770,000
Q4 2021 Feb 02, 2022	BUY	$79.7 - $88.13 $16,338 - $18,066	205 Added 3.73%	5,700 $499,000
Q3 2021 Oct 18, 2021	SELL	$81.78 - $95.14 $45,387 - $52,802	-555 Reduced 9.17%	5,495 $449,000
Q2 2021 Aug 06, 2021	BUY	$85.24 - $94.15 $46,285 - $51,123	543 Added 9.86%	6,050 $552,000
Q1 2021 Apr 27, 2021	SELL	$83.5 - $98.47 $12,191 - $14,376	-146 Reduced 2.58%	5,507 $471,000
Q4 2020 Jan 15, 2021	BUY	$78.07 - $94.43 $7,963 - $9,631	102 Added 1.84%	5,653 $534,000
Q3 2020 Oct 09, 2020	SELL	$82.14 - $91.0 $30,227 - $33,488	-368 Reduced 6.22%	5,551 $483,000
Q2 2020 Jul 08, 2020	SELL	$80.93 - $91.1 $566 - $637	-7 Reduced 0.12%	5,919 $517,000
Q1 2020 Apr 24, 2020	SELL	$70.67 - $99.01 $39,787 - $55,742	-563 Reduced 8.68%	5,926 $489,000
Q4 2019 Jan 22, 2020	SELL	$84.35 - $95.37 $88,904 - $100,519	-1,054 Reduced 13.97%	6,489 $614,000
Q3 2019 Oct 23, 2019	BUY	$85.54 - $94.26 $82,118 - $90,489	960 Added 14.58%	7,543 $655,000
Q2 2019 Aug 02, 2019	BUY	$75.4 - $92.8 $150,272 - $184,950	1,993 Added 43.42%	6,583 $601,000
Q1 2019 May 14, 2019	BUY	$75.32 - $86.15 $144,614 - $165,408	1,920 Added 71.91%	4,590 $441,000
Q4 2018 Feb 11, 2019	BUY	$73.66 - $82.02 $196,672 - $218,993	2,670 New	2,670 $229,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.

Account

Clarius Group, LLC Novartis Ag Transaction History